DK58285D0 - Peptider samt fremstilling og anvendelse deraf - Google Patents

Peptider samt fremstilling og anvendelse deraf

Info

Publication number
DK58285D0
DK58285D0 DK58285A DK58285A DK58285D0 DK 58285 D0 DK58285 D0 DK 58285D0 DK 58285 A DK58285 A DK 58285A DK 58285 A DK58285 A DK 58285A DK 58285 D0 DK58285 D0 DK 58285D0
Authority
DK
Denmark
Prior art keywords
chain
human insulin
bridging
insulin
lys
Prior art date
Application number
DK58285A
Other languages
English (en)
Inventor
-Unknown
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26064247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK58285(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DK266584A external-priority patent/DK266584D0/da
Application filed by Novo Industri As filed Critical Novo Industri As
Priority to DK58285A priority Critical patent/DK58285D0/da
Publication of DK58285D0 publication Critical patent/DK58285D0/da
Priority to GR851304A priority patent/GR851304B/el
Priority to AT90121887T priority patent/ATE143374T1/de
Priority to IE950351A priority patent/IE80630B1/en
Priority to EP90121887A priority patent/EP0427296B1/en
Priority to FI852135A priority patent/FI89183C/fi
Priority to CA000482722A priority patent/CA1304022C/en
Priority to US06/739,123 priority patent/US4916212A/en
Priority to IE133185A priority patent/IE66387B1/en
Priority to DK238585A priority patent/DK157938C/da
Priority to PT80551A priority patent/PT80551B/pt
Priority to NZ212243A priority patent/NZ212243A/en
Priority to NO852132A priority patent/NO174351C/no
Priority to AU43092/85A priority patent/AU590197B2/en
Priority to JP60116297A priority patent/JPH0630613B2/ja
Priority to AT85303775T priority patent/ATE66490T1/de
Priority to ES543594A priority patent/ES8609483A1/es
Priority to EP85303775A priority patent/EP0163529B1/en
Priority to DE8585303775T priority patent/DE3583824D1/de
Priority to DE3588125T priority patent/DE3588125T2/de
Priority to ES551941A priority patent/ES8702488A1/es
Priority to DK323687A priority patent/DK157933C/da
Priority to JP5121649A priority patent/JPH07121226B2/ja
Priority to JP5121694A priority patent/JPH0746998B2/ja
Priority to JP7142085A priority patent/JP2519023B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK58285A 1984-05-30 1985-02-08 Peptider samt fremstilling og anvendelse deraf DK58285D0 (da)

Priority Applications (25)

Application Number Priority Date Filing Date Title
DK58285A DK58285D0 (da) 1984-05-30 1985-02-08 Peptider samt fremstilling og anvendelse deraf
GR851304A GR851304B (da) 1984-05-30 1985-05-28
EP85303775A EP0163529B1 (en) 1984-05-30 1985-05-29 Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors
DE8585303775T DE3583824D1 (de) 1984-05-30 1985-05-29 Vorlaeufer des insulins, verfahren zu seiner herstellung und verfahren zur herstellung von humaninsulin aus solchen vorlaeufern des insulins.
DE3588125T DE3588125T2 (de) 1984-05-30 1985-05-29 Insulin-Vorläufer
PT80551A PT80551B (en) 1984-05-30 1985-05-29 Process for the preparation of insulin precursors useful for preparing human insulin
AU43092/85A AU590197B2 (en) 1984-05-30 1985-05-29 Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors
EP90121887A EP0427296B1 (en) 1984-05-30 1985-05-29 Insulin precursors
FI852135A FI89183C (fi) 1984-05-30 1985-05-29 Dna-sekvens som kodar foer insulinprekursorer, vektorer innehaollande denna sekvens, insulinprekursorer och foerfarande foer framstaellning av dessa samt foerfarande foer framstaellning av humaninsulin
CA000482722A CA1304022C (en) 1984-05-30 1985-05-29 Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors
US06/739,123 US4916212A (en) 1984-05-30 1985-05-29 DNA-sequence encoding biosynthetic insulin precursors and process for preparing the insulin precursors and human insulin
IE133185A IE66387B1 (en) 1984-05-30 1985-05-29 Insulin precursors process for their preparation and process for preparing human insulin from such insulin precursors
DK238585A DK157938C (da) 1984-05-30 1985-05-29 Dna-sekvens for insulinprecursorer, vektorer indeholdende denne sekvens, gaerstammer transformeret med disse vektorer samt en fremgangsmaade til fremstilling af insulinprecursorerne og en fremgangsmaade til fremstilling af humaninsulin
AT90121887T ATE143374T1 (de) 1984-05-30 1985-05-29 Insulin-vorläufer
NZ212243A NZ212243A (en) 1984-05-30 1985-05-29 Yeast strains expressing modified recombinant insulin
NO852132A NO174351C (no) 1984-05-30 1985-05-29 Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten
IE950351A IE80630B1 (en) 1984-05-30 1985-05-29 Insulin precursors
JP60116297A JPH0630613B2 (ja) 1984-05-30 1985-05-29 インシュリンの製造方法
AT85303775T ATE66490T1 (de) 1984-05-30 1985-05-29 Vorlaeufer des insulins, verfahren zu seiner herstellung und verfahren zur herstellung von humaninsulin aus solchen vorlaeufern des insulins.
ES543594A ES8609483A1 (es) 1984-05-30 1985-05-29 Un procedimiento para producir un precursor de insulina
ES551941A ES8702488A1 (es) 1984-05-30 1986-02-13 Un procedimiento para preparar un precursor de insulina
DK323687A DK157933C (da) 1984-05-30 1987-06-25 Insulinprecursorer
JP5121694A JPH0746998B2 (ja) 1984-05-30 1993-05-24 インシュリン前駆体の製造方法
JP5121649A JPH07121226B2 (ja) 1984-05-30 1993-05-24 インシュリン前駆体をコードするｄｎａ
JP7142085A JP2519023B2 (ja) 1984-05-30 1995-06-08 インシュリン前駆体

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK266584A DK266584D0 (da) 1984-05-30 1984-05-30 Dna-sekvens, der koder for en biosyntetisk insulinprecursor og fremgangsmaade til fremstilling af insulinprecursoren
DK58285A DK58285D0 (da) 1984-05-30 1985-02-08 Peptider samt fremstilling og anvendelse deraf

Publications (1)

Publication Number Publication Date
DK58285D0 true DK58285D0 (da) 1985-02-08

Family

ID=26064247

Family Applications (2)

Application Number Title Priority Date Filing Date
DK58285A DK58285D0 (da) 1984-05-30 1985-02-08 Peptider samt fremstilling og anvendelse deraf
DK323687A DK157933C (da) 1984-05-30 1987-06-25 Insulinprecursorer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK323687A DK157933C (da) 1984-05-30 1987-06-25 Insulinprecursorer

Country Status (15)

Country Link
US (1) US4916212A (da)
EP (2) EP0427296B1 (da)
JP (4) JPH0630613B2 (da)
AT (1) ATE143374T1 (da)
AU (1) AU590197B2 (da)
CA (1) CA1304022C (da)
DE (2) DE3583824D1 (da)
DK (2) DK58285D0 (da)
ES (2) ES8609483A1 (da)
FI (1) FI89183C (da)
GR (1) GR851304B (da)
IE (1) IE66387B1 (da)
NO (1) NO174351C (da)
NZ (1) NZ212243A (da)
PT (1) PT80551B (da)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DK450187D0 (da) * 1987-08-28 1987-08-28 Novo Industri As Fremgangsmaade til fremstilling af proteiner
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
DK336188D0 (da) * 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
US6875589B1 (en) * 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
DE58906966D1 (de) * 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
AU9172991A (en) 1990-12-07 1992-07-08 Cnc Development, Inc. Catalytic chemical reactor
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
CA2089541A1 (en) 1992-02-18 1993-08-19 Bruce H. Frank Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
CN101955921A (zh) 1995-03-17 2011-01-26 诺沃奇梅兹有限公司 新的内切葡聚糖酶
EP0741188A3 (en) * 1995-05-05 1999-07-14 Eli Lilly And Company Single chain insulin with high bioactivity
GB9513967D0 (en) * 1995-07-08 1995-09-06 Univ Leicester Insulin
US5840542A (en) * 1995-07-28 1998-11-24 Mogam Biotechnology Research Institute Method for manufacture of proinsulin with high export yield
ES2306685T3 (es) 1996-03-01 2008-11-16 Novo Nordisk A/S Peptido supresor del apetito, su composicion y uso.
EP1066328B1 (en) * 1998-03-31 2008-09-17 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
CN1125081C (zh) 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
WO2001046453A1 (en) 1999-12-22 2001-06-28 Novo Nordisk A/S Method for extractive refolding of scrambled single-chain polypeptides
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
US7378390B2 (en) * 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
HUP0203475A3 (en) * 1999-12-29 2005-11-28 Novo Nordisk As Method for making insulin precursors and insulin precursor analogs
BR0016860A (pt) 1999-12-29 2002-10-01 Novo Nordisk As Precursor da insulina ou análogo de precursor de insulina, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, e, processos para fabricar um precursor da insulina ou análogo de precursor de insulina, e, insulina ou um análogo de insulina
WO2001072323A2 (en) 2000-03-24 2001-10-04 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
EP1278767A4 (en) 2000-04-12 2003-11-12 Principia Pharmaceutical Corp ALBUMIN FUSED PROTEINS
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
IL157842A0 (en) 2001-03-22 2004-03-28 Novo Nordisk Healthcare Ag Coagulation factor vii derivatives
ES2333942T3 (es) * 2001-04-02 2010-03-03 Novo Nordisk A/S Precursores de insulina y proceso para su preparacion.
US7105314B2 (en) * 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
CA2446739A1 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
CZ2004427A3 (cs) 2001-09-27 2004-08-18 Novoánordiskáhealthácareáag Polypeptidy lidského koagulačního faktoru VII
EP2277889B1 (en) 2001-12-21 2014-07-09 Human Genome Sciences, Inc. Fusion proteins of albumin and interferon beta
AU2002364587A1 (en) * 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
ATE492631T1 (de) 2002-09-13 2011-01-15 Cornell Res Foundation Inc Verwendung von mutationen zur verbesserung von aspergillus-phytasen
EP1581627A4 (en) * 2002-09-13 2008-06-11 Wockhardt Ltd HEFEPROTEINEXPRESSIONSSEKRETIONSSYSTEM
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
WO2004085472A1 (en) * 2003-03-27 2004-10-07 Novo Nordisk A/S Method for making human insulin precursors and human insulin
EP1633876B1 (en) 2003-06-17 2008-08-20 SemBioSys Genetics Inc. Methods for the production of insulin in plants
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
JP2007532096A (ja) 2003-11-14 2007-11-15 ノボ　ノルディスク　アクティーゼルスカブ アシル化されたインスリンの製造方法
EP1692168B1 (en) * 2003-12-03 2011-07-20 Novo Nordisk A/S Single-chain insulin
ES2490243T3 (es) 2005-02-02 2014-09-03 Novo Nordisk A/S Derivados de insulina
ES2438145T3 (es) 2005-02-02 2014-01-16 Novo Nordisk A/S Nuevos derivados de insulina
RU2412199C2 (ru) 2005-04-18 2011-02-20 Ново Нордиск А/С Варианты ил-21
CN102660614A (zh) 2005-08-16 2012-09-12 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
WO2007031559A2 (en) 2005-09-14 2007-03-22 Novo Nordisk Health Care Ag Human coagulation factor vii polypeptides
WO2007104738A2 (en) * 2006-03-13 2007-09-20 Novo Nordisk A/S Acylated single chain insulin
US9018161B2 (en) 2006-09-22 2015-04-28 Novo Nordisk A/S Protease resistant insulin analogues
EP2069502B1 (en) 2006-09-27 2014-02-26 Novo Nordisk A/S Method for making maturated insulin polypeptides
WO2008062010A2 (en) 2006-11-22 2008-05-29 Novo Nordisk A/S Method for making activated carboxypeptidases
US7790677B2 (en) * 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
US8575096B2 (en) 2007-08-13 2013-11-05 Novo Nordisk A/S Rapid acting insulin analogues
US8962794B2 (en) 2007-08-15 2015-02-24 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
AU2008288413B2 (en) 2007-08-15 2013-09-26 Novo Nordisk A/S Insulin analogues with an acyl and aklylene glycol moiety
EP2128252A4 (en) * 2008-02-12 2011-03-16 Ils Inc FUSIONED PROTEIN WITH INSULIN PROCESSORS OF THE OVEREXPRESSION AND SECRETION TYPE, DNA THAT COVERS AND METHOD OF INSULIN PRODUCTION
JP5818681B2 (ja) 2008-04-01 2015-11-18 ノボ・ノルデイスク・エー／エス インスリンアルブミンコンジュゲート
WO2010103038A1 (en) 2009-03-11 2010-09-16 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
RU2533217C3 (ru) 2009-06-26 2020-12-21 Ново Нордиск А/С Препарат, содержащий инсулин, никотинамид и аминокислоту
AU2010272483B2 (en) 2009-07-17 2016-07-21 Omeros Corporation MASP isoforms as inhibitors of complement activation
US9096843B2 (en) 2009-12-01 2015-08-04 Novo Nordisk A/S Peptidyl α-hydroxyglycine α-amidating lyases
AU2011222883B2 (en) 2010-03-05 2016-05-26 Omeros Corporation Chimeric inhibitor molecules of complement activation
WO2011161125A1 (en) 2010-06-23 2011-12-29 Novo Nordisk A/S Insulin derivatives containing additional disulfide bonds
JP5973427B2 (ja) * 2010-06-23 2016-08-23 ノヴォ ノルディスク アー／エス 追加のジスルフィド結合を含有するインスリン類似体
CN102933599A (zh) 2010-06-23 2013-02-13 诺沃—诺迪斯克有限公司 包含额外的二硫键的人胰岛素
MX2013006174A (es) 2010-12-14 2013-07-15 Novo Nordisk As Preparacion que comprende insulina, nicotinamida y un aminoacido.
CN103249427A (zh) 2010-12-14 2013-08-14 诺沃—诺迪斯克有限公司 速效胰岛素联合长效胰岛素
JP2014509603A (ja) 2011-03-15 2014-04-21 ノヴォ ノルディスク アー／エス システイン置換を含むヒトインスリン類似体およびヒトインスリン誘導体
CN102675452B (zh) 2011-03-17 2015-09-16 重庆富进生物医药有限公司 具持续降血糖和受体高结合的人胰岛素及类似物的偶联物
US9260503B2 (en) 2011-06-15 2016-02-16 Novo Nordisk A/S Multi-substituted insulins
ES2676029T3 (es) 2012-02-09 2018-07-16 Var2 Pharmaceuticals Aps Direccionamiento de glicanos de sulfato de condroitina
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
US20150307865A1 (en) 2012-10-15 2015-10-29 Novo Nordisk Health Care Ag Coagulation factor vii polypeptides
CA2890048C (en) 2012-12-03 2022-05-03 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
US9867869B2 (en) 2012-12-12 2018-01-16 Massachusetts Institute Of Technology Insulin derivatives for diabetes treatment
US20160115216A1 (en) 2013-06-07 2016-04-28 Novo Nordisk A/S Method for Making Mature Insulin Polypeptides
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives
PL233560B1 (pl) 2014-12-05 2019-10-31 Mabion Spolka Akcyjna Sposób otrzymywania insuliny lub analogu insuliny z prekursora rekombinowanego białka
EA037848B1 (ru) 2016-07-14 2021-05-27 Общество С Ограниченной Ответственностью "Биохимический Агент" Гибридный белок, полинуклеотид, генетическая конструкция, продуцент, препарат для регенерации хряща (варианты)
CN110234339A (zh) 2016-09-06 2019-09-13 佩特雷化学和生物制药学实验室有限公司 胰岛素原衍生物
AU2018317810A1 (en) 2017-08-17 2020-03-19 Novo Nordisk A/S Novel acylated insulin analogues and uses thereof
CN112789504A (zh) 2018-07-13 2021-05-11 瓦克特诊断有限责任公司 使用重组疟疾蛋白var2csa分离胎儿来源的循环细胞
US12325732B2 (en) 2018-09-12 2025-06-10 Amphastar Nanjing Pharmaceuticals Inc Pro-insulin aspart structure and method for preparing insulin aspart
WO2021136293A1 (zh) 2019-12-30 2021-07-08 甘李药业股份有限公司 胰岛素衍生物
JP2023510218A (ja) 2019-12-30 2023-03-13 ガン アンド リー ファーマスゥーティカルズ カンパニー リミテッド 長時間作用型ｇｌｐ－１化合物
WO2022049409A1 (en) 2020-09-02 2022-03-10 Sia Terragen Express diagnosticum for sars-cov-2
WO2023144240A1 (en) 2022-01-26 2023-08-03 Novo Nordisk Research Centre Oxford Limited Glucose sensitive insulin derivatives and uses thereof
EP4471053A1 (en) 2022-01-28 2024-12-04 Gan & Lee Pharmaceuticals Co., Ltd. Acylated insulin

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440859A (en) * 1977-05-27 1984-04-03 The Regents Of The University Of California Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
US4431740A (en) * 1979-09-12 1984-02-14 The Regents Of The University Of California DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes
IE50892B1 (en) * 1980-02-11 1986-08-06 Novo Industri As Process for preparing insulin esters
CA1202581A (en) * 1980-03-27 1986-04-01 Saran A. Narang Adaptor molecules for dna and their application to synthesis of gene-derived products
YU76881A (en) * 1980-03-27 1984-04-30 Lilly Co Eli Process for obtaining insulin precursors
ZA811895B (en) * 1980-04-07 1982-04-28 Univ California Expression of hormone genomic clones
JPS5750948A (en) * 1980-09-12 1982-03-25 Shionogi & Co Ltd Insulin analog and preparation
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
CA1204682A (en) * 1981-06-19 1986-05-20 Saran A. Narang Adaptors, and synthesis and cloning of proinsulin genes
ZA824218B (en) * 1981-06-29 1983-04-27 Cetus Corp Plasmid for producing human insulin
AU560472B2 (en) * 1981-08-25 1987-04-09 Celltech Limited Yeast expression vectors
MC1586A1 (fr) * 1982-03-31 1985-02-22 Genetics Inst Preparation de sequences d'adn codant pour des precurseurs de pro-insuline modifies
WO1983003413A1 (en) * 1982-03-31 1983-10-13 Genetics Inst Creation of dna sequences encoding modified proinsulin precursors
DK172738B1 (da) * 1983-04-07 1999-06-21 Chiron Corp Fremgangsmåde til at udtrykke modent insulin og DNA-struktur til anvendelse ved fremgangsmåden
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
UA41863C2 (uk) * 1985-10-25 2001-10-15 Займодженетікс Інк. Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмах

Also Published As

Publication number Publication date
FI89183C (fi) 1993-08-25
JPS611389A (ja) 1986-01-07
ES8609483A1 (es) 1986-09-01
IE66387B1 (en) 1995-12-27
PT80551B (en) 1987-04-09
IE851331L (en) 1985-11-30
JPH07121226B2 (ja) 1995-12-25
DK323687A (da) 1987-06-25
CA1304022C (en) 1992-06-23
US4916212A (en) 1990-04-10
DK157933C (da) 1990-08-27
JPH0746998B2 (ja) 1995-05-24
JPH06141866A (ja) 1994-05-24
NO174351C (no) 1994-04-20
AU590197B2 (en) 1989-11-02
JPH0630613B2 (ja) 1994-04-27
ES8702488A1 (es) 1986-12-16
EP0427296B1 (en) 1996-09-25
FI852135L (fi) 1985-12-01
FI852135A0 (fi) 1985-05-29
JPH07309896A (ja) 1995-11-28
ES551941A0 (es) 1986-12-16
DE3588125T2 (de) 1997-02-13
GR851304B (da) 1985-11-25
NZ212243A (en) 1988-05-30
EP0163529A1 (en) 1985-12-04
AU4309285A (en) 1985-12-05
DE3583824D1 (de) 1991-09-26
JPH06141865A (ja) 1994-05-24
DK157933B (da) 1990-03-05
ES543594A0 (es) 1986-09-01
FI89183B (fi) 1993-05-14
JP2519023B2 (ja) 1996-07-31
PT80551A (en) 1985-06-01
EP0163529B1 (en) 1991-08-21
DK323687D0 (da) 1987-06-25
EP0427296A1 (en) 1991-05-15
NO174351B (no) 1994-01-10
ATE143374T1 (de) 1996-10-15
NO852132L (no) 1985-12-02
DE3588125D1 (de) 1996-10-31

Similar Documents

Publication Publication Date Title
DK58285D0 (da) Peptider samt fremstilling og anvendelse deraf
EP0150126A3 (en) The synthesis of protein with an identification peptide
ES8801674A1 (es) Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
NZ513422A (en) G-CSF analogues that do not possess any hematopoietic activity and are useful as antagonists against G-CSF effect, such as overproduction of G-CSF
DK336188D0 (da) Propeptider
ES8802235A1 (es) Procedimiento para preparar un polipeptido
IL74426A (en) Atrial peptides and pharmaceutical compositions comprising them
EP0195680A3 (en) The synthesis of protein with an identification peptide
DE3380819D1 (en) A precursor of a c-terminal amidated peptide and production thereof
ES2044928T3 (es) Enzima alfa-amidante en terminal c y procedimiento para la produccion y el uso del mismo.
NZ216316A (en) Hepta and octapeptides with thymic humoral activity
ATE78872T1 (de) Herstellung von polypeptiden.
DK238585A (da) Peptider og fremstilling deraf
WO1990000179A3 (fr) Nouvelles proteins, adn les codant et leur usage
EP0327360A3 (en) Novel polypeptides and dna encoding said polypeptides
Christiansen Synthetic yeast leader peptides
EP0266006A3 (en) Novel hypotensive diuretic peptides
DE3686036D1 (en) New fusion protein contg. small interleukin 2 ballast fragments
GB1210557A (en) Synthesis of polypeptides containing cysteine
CA1267086C (en) METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES
DK301090A (da) Insulinprecursorer